by the pituitary and stimulates ovulation and sperma¬ togenesis as well as androgen production by the gonads. As long ago as 1980, however, a CG or CG-like substance, distinct from LH-/3, was detected in extracts from normal human pituitary glands (1, 2) and found to circulate at low levels in non-pregnant women and in men (3) . In 1982, CG-/3 immunopositive cells were identified in the normal, non-pregnant pituitary (4, 5) and, subse¬ quently, pulsatile secretion of CG-/3 was shown to occur in normal adults, including at least 70% of adult men (mean of 8.9 ng/1 in contrast to 111 ng/1 in postmenopausal women) (6) . Chorionic gonadotrophin ß has been shown also to be released with approximately the same pulse frequency as LH and to be responsive to sex steroids and GnRH (7) . Occult (9) , and scattered LH/CG-/3-positive cells have been found previously in 25-40% of somatotroph adenomas and a lower percentage of endocrinologically inactive adenomas using methods that could not distinguish between the two (10, 11) . We have used a CG-/3-speciflc oligodeoxynucleotide probe to distinguish CG-ß from LH-/J transcripts in a survey of 3 (Fig. 1) . A similar pattern of LH/CG-/3 positivity was seen immunocytochemically (Fig. 2) .
It can be seen from the autoradiographs of simul¬ taneously hybridized placenta and pituitary that the LH/CG-/3 and the CG-/3-specific oligonucleotide probe clearly distinguished CG-/3 transcripts from LH/CG-/3 transcripts (Fig. 3) . Use of the same probes in sections from the 3 5 pituitary adenomas examined showed that transcripts containing the 5' non-coding regions unique to CG were present in two adenomas: from a 42-year-old male acromegalie (shown in Fig. 3) (27) . Nevertheless, there is good evidence for the presence of bona fide CG-ß transcripts in mid-trimester fetal kidney and adrenal tissue (28) , and for CG-/3 production by normal pituitary tissue (2, 29 Table 1 and shown in Fig. 3 ) and found in a scattered distribution similar to that observed for LH-/3 transcripts in an endocrinologically inactive adenoma from an 82-year-old male (shown in Fig. 1 ). The frequency of CG-ß expression in the random selection of pituitary adenomas examined in this study was therefore only around 5%, which compares with an average incidence of ectopie CG-/3 expression or CG-like immunoactivity in carcinomas of between 6% and 13% (30) . Our finding of CG-ß transcripts in only one of 15 endocrinologically inactive adenomas is considerably less than the reported incidence of immunocytochemically detected CG-/3 in a recent study (31) . Whether this reflects lower immunocytochemical specificity than expected (31), or reduced hybridization sensitivity using the oligodeoxynucleotide and ribonucleotide probes in the pre¬ sent study, is difficult to determine. As (32, 33) .
